Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The flow diverters market is emerging as a significant segment within neurovascular treatment, driven by advances in technology and increasing awareness of aneurysm management. As medical professionals seek more effective and less invasive treatment options, this market is set to experience notable growth in the coming years. Let’s explore the current market size, key factors driving demand, segmentation, evolving trends, major players, and geographic insights shaping the industry.

Flow Diverters Market Size and Growth Forecast Through 2030

The flow diverters market has seen rapid expansion over recent years. It is projected to increase from $0.55 billion in 2025 to $0.62 billion in 2026, reflecting a strong compound annual growth rate (CAGR) of 11.7%. This historical growth stems from limited availability of specialized flow diverters, dependence on traditional surgical methods like clipping and coiling, growing awareness about intracranial aneurysm treatments, enhanced neurovascular capabilities in hospitals and clinics, and the use of early-generation nitinol stents. Looking ahead, the market is expected to reach $0.95 billion by 2030, with a CAGR of 11.4%. This anticipated surge is tied to the development of next-generation flow diverters offering improved flexibility, an increasing preference for minimally invasive neurovascular procedures, investments in hospital endovascular infrastructure, rising regulatory approvals for new devices, and integration of imaging with AI-assisted deployment techniques. Key trends forecasted include broader use of flow diverters for complex aneurysms, advancement in nitinol and cobalt-chromium devices, expansion of specialized treatment centers, and a focus on improving patient safety by reducing procedure complications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24539&type=smp

Primary Factors Supporting Flow Diverters Market Growth

One of the main forces propelling demand for flow diverters is the rising prevalence of aneurysms. These are abnormal bulges or balloon-like expansions in blood vessel walls caused by weakening, primarily affecting aging populations. Improved diagnostic technologies have increased detection rates, resulting in a higher number of diagnosed aneurysm cases and greater awareness among patients and healthcare providers. Flow diverters address this growing need by redirecting blood flow away from the weakened vessel areas, promoting healing, lowering rupture risks, and providing a less invasive alternative to traditional surgery. For instance, a November 2025 report from PubMed, a U.S.-based biomedical literature database, highlighted that around 3% of adults carry an unruptured intracranial aneurysm, with prevalence rising to 10% among high-risk groups. This growing patient pool is a key driver behind the expanding market for flow diverters.

Detailed Segmentation and Revenue Opportunities in the Flow Diverters Market

This market is categorized into several segments to provide a comprehensive view of offerings and applications:

1) By Type: Pipeline Embolization Device, Silk Flow Diverter, Surpass Flow Diverter, Flow Redirection Endoluminal Device, and Other Types

2) By Material: Nitinol, Cobalt-Chromium Alloy, Stainless Steel, and Other Materials

3) By Application: Intracranial Aneurysms, Arteriovenous Malformations, Complex Wide-Neck Aneurysms, and Other Applications

4) By End-User: Hospitals and Clinics, Ambulatory Surgical Centers

Access The Complete Flow Diverters Market Report:

https://www.thebusinessresearchcompany.com/report/flow-diverters-global-market-report

Further subtypes include various models within each device category, such as Classic, Flex, and Shield technology versions of the Pipeline Embolization Device; Silk+ and Silk Vista Baby for Silk Flow Diverters; Surpass Streamline and Surpass Evolve; FRED Jr. and FRED X under Flow Redirection Endoluminal Devices; and other options like DERIVO Embolization Device, p64 Flow Modulation Device, and Tubridge Flow Diverter. This detailed segmentation highlights diverse product portfolios catering to different clinical and patient needs.

Innovations and Trends Transforming the Flow Diverters Industry

Leading companies in the flow diverters market are focusing heavily on material science breakthroughs, especially the development of polymer-based neurovascular stents. These devices aim to improve performance by enhancing biocompatibility, encouraging natural vessel healing, and minimizing reliance on long-term blood-thinning medications. For example, in June 2023, Fluid Biomed, a Canadian medical device startup, announced the world’s first human implantation of a fully polymer-based neurovascular stent called the ReSolv stent, designed specifically to treat brain aneurysms. Unlike conventional hybrid polymer-metal stents, the ReSolv stent dissolves gradually as the vessel heals, potentially reducing the need for extended blood-thinner use while supporting natural vessel recovery. Such innovations are key to advancing patient outcomes and expanding the scope of flow diverter applications.

Key Players Driving the Flow Diverters Market Forward

Several prominent companies shape the competitive landscape of the flow diverters market, including Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Penumbra Inc., Phenox GmbH, Sino Medical Sciences Technology Inc., Balt Extrusion S.A.S., Sequent Medical Inc., Wallaby Medical Ltd., Zylox Tonbridge Medical Technology Co. Ltd., Acandis GmbH & Co. KG, Fluid Biomed Inc., Oxford Endovascular Ltd., EndoStream Medical Ltd., Rapid Medical Ltd., Cerus Endovascular Ltd., NeuroVasc Technologies Inc., Shape Memory Medical Inc., and Vesalio LLC. These organizations lead innovation, product development, and market expansion efforts globally.

Regional Growth Patterns in the Flow Diverters Market

In 2025, North America held the largest share of the flow diverters market, underscoring its mature healthcare infrastructure and high adoption rates of advanced neurovascular technologies. Meanwhile, the Asia-Pacific region is anticipated to experience the fastest growth during the forecast period, driven by increasing healthcare investments, rising awareness of neurovascular conditions, and expanding hospital capabilities. The overall market report includes insights across key regions such as Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad perspective on global market dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model